Report Description

The global chemotherapy at home services market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing incidences of different types of cancer, and rising preferences towards at-home medical care, are bolstering the growth of the market. Chemotherapy is a medical practice that is mainly conducted for cancer patients. It uses powerful chemicals to kill fast growing cells in human body. The other factors supporting the market’s growth are growing need to reduce the period of inpatient stays, the increasing population, changing societal behavior, increasing government investments, growth in geriatric population, and technological advancements in field of chemotherapy devices. Also, strategic partnerships and collaborations are fueling the growth of the market. For instance, CVS Health and the Cancer Treatments Centers of America (CTCA) worked in partnership to bolster the access to chemotherapy at home for eligible patients.

Increasing Incidence of Cancer and Rise in Geriatric Population

Rise in occurrences of various types of cancer such as lung cancer, cervical cancer, breast cancer, and others, are propelling the growth of the market. Cancer is considered as second largest cause of mortality and disability across the globe. According to National Cancer Institute, roughly 5.5 million people in the United States are affected by cancer. This number is projected to rise to 20.3 million by 2026. Owing to the rapid increase in number of patients suffering from cancer, the surge in demand for chemotherapy rises, which augments the growth of chemotherapy at home services market, globally. Furthermore, rising geriatric population is also a key factor contributing the growth of the market. For instance, according to the U.S. Census Bureau, approximately 77.0 million people will be aged 65 & above by 2034, and this number is anticipated to reach 94.7 million by 2060.

Increasing Preference for At-Home Medical Care and Various Technological Advancements

Rising consumer inclination toward at-home medical care is bolstering the market growth, globally. The limited movement capabilities by elderly population are fueling the growth of the market. Rising incidences of hospital infections, and cost effectiveness of these devices are curbing the market growth. For instance, in 2021, as per the study, titled ‘Predicting Patients at Risk for Prolonged Hospital Stays’, only 1.2% of hospital stays lasted more than 21 days. Moreover, various initiatives are taken by government and non-government organization to bolster the growth of the market. In 2021, VS Health and the Cancer Treatments Centers of America (CTCA) collaborated to augment the access to chemotherapy at home for qualified patients.


Download Free Sample Report

Market Segmentation

The global chemotherapy at home services market is segmented into product, route of administration, cancer type, and company. Based on product, the market is divided into chemotherapy drugs and chemotherapy infusion pumps. Based on route of administration, the market is segmented into oral and intravenous. Based on cancer type, the market is segmented into breast cancer, blood cancer, ovarian cancer, colorectal cancer, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising prevalence of different type of cancer and rising geriatric population base in the country.

Market Players

Portea Medical Pvt. Ltd., HealthCare atHOME, Ubiqare Health Pvt. Ltd., Vitalis Health and Home Care Pty Ltd, Medibank Private Limited, Advocate Medical Group, View Health Pty Ltd, and CVS Health Corporation are some of the leading companies operating in the market.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, Volume Units and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, Volume forecast company share, competitive landscape, growth factors, and trends

Segments covered

·         Product

·         Route of Administration  

·         Cancer Type

·         Company

Regional scope

North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; China; India; Japan; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa

Key companies profiled

Portea Medical Pvt. Ltd., HealthCare atHOME, Ubiqare Health Pvt. Ltd., Vitalis Health and Home Care Pty Ltd, Medibank Private Limited, Advocate Medical Group, View Health Pty Ltd, and CVS Health Corporation

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Report Scope:

In this report, global chemotherapy at home services market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         Chemotherapy At Home Services Market, By Product:

    • Chemotherapy Drugs
    • Chemotherapy Infusion Pumps

·         Chemotherapy At Home Services Market, By Route of Administration:

o    Oral

o    Intravenous

·         Chemotherapy At Home Services Market, By Cancer Type:

    • Breast Cancer
    • Blood Cancer
    • Ovarian Cancer
    • Colorectal Cancer
    • Others

·         Chemotherapy At Home Services Market, By Region:

    • North America
      • United States
      • Canada
      • Mexico
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
    • Europe & CIS
      • Germany
      • France
      • United Kingdom
      • Spain
      • Italy
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Chemotherapy At Home Services Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Chemotherapy At Home Services Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Service Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Chemotherapy At Home Services Market

4.    Executive Summary

5.    Voice of Customer

5.1.  Cancer Prevalence, By Gender

5.2.  Cancer Prevalence, By Age Group

5.3.  Cancer Prevalence, By Region

5.4.  Factors Contributing Switch To Chemotherapy At Home

5.5.  Barriers To Adoption of Chemotherapy At Home Services

6.    Global Chemotherapy At Home Services Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product (Chemotherapy Drugs v/s Chemotherapy Infusion Pumps)

6.2.2.     By Route of Administration (Oral v/s Intravenous)

6.2.3.     By Cancer Type (Breast Cancer, Blood Cancer, Ovarian Cancer, Colorectal Cancer, Others)

6.2.4.     By Company (2021)

6.2.5.     By Region

6.3.  Market Map

7.    North America Chemotherapy At Home Services Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Product

7.2.2.     By Route of Administration

7.2.3.     By Cancer Type

7.2.4.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Chemotherapy At Home Services Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Product

7.3.1.2.2.             By Route of Administration

7.3.1.2.3.             By Cancer Type

7.3.2.     Mexico Chemotherapy At Home Services Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Product

7.3.2.2.2.             By Route of Administration

7.3.2.2.3.             By Cancer Type

7.3.3.     Canada Chemotherapy At Home Services Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Product

7.3.3.2.2.             By Route of Administration

7.3.3.2.3.             By Cancer Type

8.    Europe Chemotherapy At Home Services Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Product

8.2.2.     By Route of Administration

8.2.3.     By Cancer Type

8.2.4.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Chemotherapy At Home Services Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Product

8.3.1.2.2.             By Route of Administration

8.3.1.2.3.             By Cancer Type

8.3.2.     Germany Chemotherapy At Home Services Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Product

8.3.2.2.2.             By Route of Administration

8.3.2.2.3.             By Cancer Type

8.3.3.     United Kingdom Chemotherapy At Home Services Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Product

8.3.3.2.2.             By Route of Administration

8.3.3.2.3.             By Cancer Type

8.3.4.     Italy Chemotherapy At Home Services Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Product

8.3.4.2.2.             By Route of Administration

8.3.4.2.3.             By Cancer Type

8.3.5.     Spain Chemotherapy At Home Services Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Product

8.3.5.2.2.             By Route of Administration

8.3.5.2.3.             By Cancer Type

9.    Asia-Pacific Chemotherapy At Home Services Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Product

9.2.2.     By Route of Administration

9.2.3.     By Cancer Type

9.2.4.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Chemotherapy At Home Services Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Product

9.3.1.2.2.             By Route of Administration

9.3.1.2.3.             By Cancer Type

9.3.2.     India Chemotherapy At Home Services Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Product

9.3.2.2.2.             By Route of Administration

9.3.2.2.3.             By Cancer Type

9.3.3.     Japan Chemotherapy At Home Services Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Product

9.3.3.2.2.             By Route of Administration

9.3.3.2.3.             By Cancer Type

9.3.4.     South Korea Chemotherapy At Home Services Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Product

9.3.4.2.2.             By Route of Administration

9.3.4.2.3.             By Cancer Type

9.3.5.     Australia Chemotherapy At Home Services Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Product

9.3.5.2.2.             By Route of Administration

9.3.5.2.3.             By Cancer Type

10.  South America Chemotherapy At Home Services Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Product

10.2.2.  By Route of Administration

10.2.3.  By Cancer Type

10.2.4.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Chemotherapy At Home Services Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Product

10.3.1.2.2.           By Route of Administration

10.3.1.2.3.           By Cancer Type

10.3.2.  Argentina Chemotherapy At Home Services Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Product

10.3.2.2.2.           By Route of Administration

10.3.2.2.3.           By Cancer Type

10.3.3.  Colombia Chemotherapy At Home Services Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Product

10.3.3.2.2.           By Route of Administration

10.3.3.2.3.           By Cancer Type

11.  Middle East and Africa Chemotherapy At Home Services Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Product

11.2.2.  By Route of Administration

11.2.3.  By Cancer Type

11.2.4.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Chemotherapy At Home Services Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Product

11.3.1.2.2.           By Route of Administration

11.3.1.2.3.           By Cancer Type

11.3.2.  Saudi Arabia Chemotherapy At Home Services Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Product

11.3.2.2.2.           By Route of Administration

11.3.2.2.3.           By Cancer Type

11.3.3.  UAE Chemotherapy At Home Services Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Product

11.3.3.2.2.           By Route of Administration

11.3.3.2.3.           By Cancer Type

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Portea Medical Pvt. Ltd.

14.2.              HealthCare atHOME

14.3.              Ubiqare Health Pvt. Ltd.

14.4.              Vitalis Health and Home Care Pty Ltd

14.5.              Medibank Private Limited.

14.6.              Advocate Medical Group

14.7.              View Health Pty Ltd

14.8.              CVS Health Corporation

15.          Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Growing incidences of various types of cancer and rising geriatric population are driving the demand for the global chemotherapy at home services market.

down-arrow

Portea Medical Pvt. Ltd., HealthCare atHOME, Ubiqare Health Pvt. Ltd., Vitalis Health and Home Care Pty Ltd, Medibank Private Limited, Advocate Medical Group, View Health Pty Ltd, and CVS Health Corporation are the key players operating in the global chemotherapy at home services market.

down-arrow

The lack of skilled manpower coupled with vast product recalls and lack of standard usage guidelines can hamper the growth of the global chemotherapy at home services market.

down-arrow

The Global Chemotherapy At Home Services Market is studied from 2017 to 2027.